Search company, investor...

Zogenix's alternatives and competitors

See how Zogenix compares to similar products. Zogenix's top competitors include Zyla Life Sciences, Charleston Laboratories, and Intarcia Therapeutics.

Zyla Life Sciences is a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indi…

Zogenix vs. Zyla Life Sciences

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Zogenix to Competitors

N
NeuroMolecular Pharmaceuticals

NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline of neuropsychiatric products based upon its scientists' unique understanding of glutamate's central role in mediating CNS disorders. NeuroMolecular is rapidly advancing its next-generation medicines into clinical studies, with preclinical programs underway in depression, pain, Alzheimer's disease, Parkinson's disease, multiple sclerosis and epilepsy. NeuroMolecular is initially focusing on the development of superior derivatives and dosage formulations of memantine, a drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer's disease.

E
Emagin Therapeutics

Emagin Therapeutics develops new and improved drug entities to treat acute, chronic and cancer-related pain and delivery systems for pain management.

N
NaryxPharma

Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations.

Orexo Logo
Orexo

Orexo is a pharmaceutical company that focuses on the development of improved pharmaceuticals. The company's main offerings include innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Orexo primarily sells to the healthcare industry. It is based in Uppsala, Sweden.

Q
Quark Pharmaceuticals

Quark Pharmaceuticals is a development-stage pharmaceutical company discovering and developing RNA interference (RNAi)-based therapeutics.

U
Urigen Pharmacueticals

Urigen Pharmaceuticals focuses on the development and commercialization of innovative products for urological indications within the healthcare sector. The company specializes in creating treatments aimed at alleviating the causes and symptoms of urological ailments, particularly Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). It is based in North Brunswick, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.